MAPT and Alzheimer disease: Our results thus suggest that increased CTh (and reduced MD) are related to inflammation in early preclinical stages whereas reduced CTh (and increased MD) are more closely related to tau aggregation, which drives local neurodegeneration in later preclinical and prodromal AD stages.33